JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Banks, W. A.
Right arrow Articles by Morley, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Banks, W. A.
Right arrow Articles by Morley, J. E.

Vol. 299, Issue 2, 536-541, November 2001

Intravenous Human Interleukin-1alpha Impairs Memory Processing in Mice: Dependence on Blood-Brain Barrier Transport into Posterior Division of the Septum

William A. Banks, Susan A. Farr, Michael E. La Scola and John E. Morley

Geriatric Research, Education, Clinical Center, Veterans Affairs Medical Center, St. Louis, Missouri; and Department of Internal Medicine, Division of Geriatrics, St. Louis University School of Medicine, St. Louis, Missouri

Peripherally administered cytokines profoundly affect the central nervous system (CNS). One mechanism by which they could affect the CNS is by crossing the blood-brain barrier (BBB) to interact directly with brain receptors. Human and murine IL-1alpha (hIL-1alpha ; mIL-1alpha ) are transported across the murine BBB with a high rate of transport into the posterior division of the septum (PDS), but it is unknown whether BBB transport is relevant to their actions. Here, we injected species-specific blocking antibodies into the PDS to determine whether transport across the BBB is required for blood-borne hIL-1alpha to affect memory. Retention was impaired in a dose-dependent manner when hIL-1alpha was injected either by tail vein (i.v.) or into the PDS, with the PDS route being 1000 times more potent. About 70% of the memory impairment induced by i.v. hIL-1alpha was reversed by injecting a blocking antibody (Ab) specific for hIL-1alpha into the PDS. This shows that much of the memory impairment induced by hIL-1alpha depends on its ability to cross the BBB. Ab specific for mIL-1alpha was also effective in reversing memory impairment, showing that hIL-1alpha releases mIL-1alpha from endogenous stores. Whether the mIL-1alpha was released from peripheral stores, which would require it to cross the BBB, or from brain stores is unknown. In conclusion, these results show that exogenous, blood-borne hIL-1alpha affects memory by releasing mIL-1alpha from endogenous stores and by crossing the BBB to act at sites within the PDS.

0022-3565/01/2992-0536$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2001 by U.S. Government


This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
L. B. Jaeger, W. A. Banks, J. L. Varga, and A. V. Schally
Antagonists of growth hormone-releasing hormone cross the blood-brain barrier: A potential applicability to treatment of brain tumors
PNAS, August 30, 2005; 102(35): 12495 - 12500.
[Abstract] [Full Text] [PDF]

Home page
 J. Gerontol. A Biol. Sci. Med. Sci.Home page
J. E. Morley and R. N. Baumgartner
Cytokine-Related Aging Process
J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2004; 59(9): M924 - M929.
[Full Text] [PDF]

Home page
 J. Gerontol. A Biol. Sci. Med. Sci.Home page
J. H. Flaherty and J. E. Morley
Delirium: A Call to Improve Current Standards of Care
J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2004; 59(4): M341 - M343.
[Full Text] [PDF]

Home page
 J. Gerontol. A Biol. Sci. Med. Sci.Home page
D. R. Thomas
The Relationship Between Functional Status and Inflammatory Disease in Older Adults
J. Gerontol. A Biol. Sci. Med. Sci., November 1, 2003; 58(11): M995 - 998.
[Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
N. Nonaka, S. Shioda, M. L. Niehoff, and W. A. Banks
Characterization of Blood-Brain Barrier Permeability to PYY3-36 in the Mouse
J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 948 - 953.
[Abstract] [Full Text] [PDF]

Home page
 J. Gerontol. A Biol. Sci. Med. Sci.Home page
W. A. Banks and J. E. Morley
Memories Are Made of This: Recent Advances in Understanding Cognitive Impairments and Dementia
J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2003; 58(4): M314 - 321.
[Full Text] [PDF]

Home page
 J. Gerontol. A Biol. Sci. Med. Sci.Home page
J. E. Morley
Anorexia and Weight Loss in Older Persons
J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2003; 58(2): M131 - 137.
[Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.